INTRODUCTION
Asymptomatic deep venous thrombosis (DVT) represents one of the most common complications after total joint arthroplasty. [1] [2] [3] [4] [5] [6] [7] Due to the lack of symptoms, the condition goes mostly unnoticed and, hence, the patient untreated. Little is known about the long-term sequelae arising from asymptomatic DVT, especially its role in the development of post-thrombotic syndrome.
Post-thrombotic syndrome comprises a range of clinical signs and symptoms that vary in degree. It is a chronic complication that includes valve damage or outflow obstruction, resulting in vein dilatation and valvular incompetence. [8] [9] [10] [11] Information on the incidence of asymptomatic DVT arising as a complication of total joint arthroplasty is scarce in the literature. 12 Although problems relating to pulmonary embolism are well-recognised, long-term morbidity resulting from post-thrombotic syndrome continues to be undervalued in clinical practice. 13, 14 We aimed to measure the likelihood of developing signs of post-thrombotic syndrome within postoperative 15 to 24 months in patients with asymptomatic DVT after total hip or knee arthroplasty.
MATERIALS AND METHODS
A total of 132 consecutive patients (61 women and 71 men) with a mean age of 62 years (range, 48-83 years) were included. 85 patients underwent total knee arthroplasty (TKA) and 47 total hip arthroplasty (THA); all received epidural anaesthesia with sedation. In preoperative assessment, both lower extremities were thoroughly examined to exclude signs of venous insufficiency including oedema, varicosis, or trophic skin changes. Patients with apparent signs of postthrombotic syndrome, previous lower-limb DVT, or a history of major lower-limb surgery including joint replacements were excluded. 12 patients, who had undergone uneventful arthroscopic procedures at least 6 months prior to admission, were also included.
All patients received low-molecular-weight heparin as prophylaxis, which was administered from postoperative 6 hours until discharge. The mean hospital stay was 7 days (range, 5-12 days). Colour duplex scan was performed 5 to 7 days after surgery. Patients with thrombi were classified by thrombi location: below the popliteal level within the calf veins (distal thrombi), or within the popliteal and femoral veins (proximal thrombi). Patients with proximal thrombi received warfarin, whereas patients with distal thrombi received 150 mg of aspirin daily. The treatment period was standardised to 3 months for both groups.
All proximal DVTs were monitored with repeated colour duplex scanning at 4-to-6-week intervals. In cases of established popliteal or femoral DVT, patients were assessed using repeated colour duplex scans until definitive signs of clot resolution were present. Within 15 to 24 months (mean, 18 months) after surgery, all patients were followed up with a questionnaire (Table  1) focusing on clinical symptoms and signs associated with the development of post-thrombotic syndrome. Questions were directed towards residual calf or ankle swelling, oedema, pain at rest or during activity, dryness of skin, pigmentation or discolouration of skin, newly developed varicosis, breakdown of skin (ulcera), tingling, or cramps. Patients were allowed to elaborate on any of the symptoms mentioned or on other symptoms that might have developed. Patients who reported symptoms were re-examined. The degree of post-thrombotic syndrome was classified according to criteria defined by the International Consensus Committee on Chronic Venous Disease (Table 2) . 15 Student's t test was used for statistical analysis.
RESULTS
The overall incidence of asymptomatic DVT occurring within postoperative 7 days was 36.4% (48 patients: 27 female and 21 male)-below the knee in 42 patients and above the knee in 6 patients. Clot propagation was observed in 3 cases, 2 of which originally suffered below-knee DVT. Six patients with below-knee involvement were affected bilaterally. Signs of thrombophlebitis were recorded in 2 patients: one had distal DVT, the other proximal DVT; both later developed signs of post-thrombotic syndrome. No patients receiving warfarin or aspirin had side-effects or complications during the treatment period. Signs of thrombus resolution were recorded postoperatively in a mean of 6 weeks (range, 4-12 weeks).
Of the 132 patients, 117 (75 TKA and 42 THA) responded to the questionnaire (response rate, 89%) in postoperative 15 to 24 months. Of the 117 respondents, 42 had previously been affected by asymptomatic DVT. Transient calf or ankle swelling was recorded in 17 of 42 patients with asymptomatic DVT and in 15 of 75 patients without DVT. Persistent oedema was present in 10 of 42 patients with asymptomatic DVT and in one of 75 patients without DVT.
Of the 42 patients previously affected by asymptomatic DVT, 17 reported ongoing problems and were re-examined. Seven had developed objective signs of post-thrombotic syndrome (Table 3) . No patient developed overt ulceration within the study period.
Total knee arthroplasty group
Asymptomatic DVT developed in 32 (37.6%) of 85 patients receiving TKA, with all thrombi located in the calf veins below the popliteal level. Clot propagation into the popliteal vein was noted in one patient, who also developed signs of thrombophlebitis. Of the 32 patients, 28 were available for follow-up: 11 reported transient leg or ankle swelling, 6 presented with chronic lower-leg oedema, the remaining 11 were symptom free. Four patients developed signs of post-thrombotic syndrome: 3 classified as class 2/3 representing mild, and one as class 4 representing moderate. In a mean of postoperative 18 months, the incidence of postthrombotic syndrome in patients affected by asymptomatic DVT was 14.3% (4 out of 28), while the overall incidence of post-thrombotic syndrome in all TKA patients available for follow-up was 5.3% (4 out of 75).
Total hip arthroplasty group
Asymptomatic DVT developed in 16 (34.0%) of the 47 patients receiving THA: 10 located in the calf veins below the popliteal level, 6 involving the popliteal and femoral veins. Clot propagation was observed in one patient with below-knee DVT and another with aboveknee DVT. Thrombophlebitis developed in one case of above-knee DVT. Of the 16 patients, 14 were available for follow-up: 6 reported transient leg or ankle swelling, 4 presented chronic lower leg oedema, the remaining 4 were symptom free. incidence of post-thrombotic syndrome in patients affected by asymptomatic DVT was 21.4% (3 out of 14), while the overall incidence of post-thrombotic syndrome in all THA patients available for followup was 7.1% (3 out of 42).
DISCUSSION
DVT is a common complication following total joint arthroplasty, with incidence reported between 30% and 70%, most of which is asymptomatic. [1] [2] [3] [4] [5] [6] [7] 16 Localised and systemic complications can arise from DVT, with pulmonary embolism representing the most devastating systemic thrombo-embolic complication after joint replacement surgery. Nonetheless, the reported mortality rates are low, with a mean incidence of 0.1% to 1.0%. [17] [18] [19] Localised problems, such as post-thrombotic syndrome, pose a far more common risk to patients with DVT and appear to be underestimated in clinical practice. 8, 10, 13, 14 Reported rates of asymptomatic DVT without primary prophylaxis range from 20% to 58%, with 1.5% to 8% detected in the femoral vein.
1,2,5
D e s p i t e t h e a d m i n i s t r a t i o n o f p r i m a r y chemoprophylaxis such as warfarin or aspirin, the incidence of asymptomatic DVT remains high, with reported figures ranging from 34% to 61%, of which 2.5% to 9.1% are located proximally. 3, 4, 6, 7, 16 These findings are similar to our results revealing a DVT rate of 37.6% in knee patients and 34.0% in hip patients. There was no significant difference between the 2 groups. The rate of s y m p t o m a t i c D V T f o l l o w i n g t o t a l j o i n t arthroplasty has been reported to be much lower, ranging from 2.1% to 12.5%, with 50% to 85% situated above the knee. 5, 20 Once developed, a thrombus can further enlarge and propagate proximally, as occurred in 6.3% of patients with asymptomatic distal DVT in the current study. The occurrence of proximal clot propagation varies and has not been reported; nonetheless, available figures seem to range between 5% and 23%, representing a substantial risk to patients if left untreated. 9, [21] [22] [23] Venography is an invasive, inconvenient, and expensive screening method. It has been associated with risks of allergic reaction, post-venographic phlebitis, and clot propagation. Table 3 Clinical details of patients with post-thrombotic syndrome (PTS) many consider it the gold standard, it is impractical to use due to its invasiveness and possible thrombogenic potential, especially for repeated investigations. With sensitivity values between 67% and 91%, and specificity values between 97% and 99%, colour duplex ultrasound has become the assessment tool of choice. 16, [25] [26] [27] [28] [29] However, the reliability of ultrasound in assessing DVT depends on the experience of the investigator, especially when assessing calf vein thrombi.
1 30 and may help to further enhance the reliability of DVT diagnosis by reducing the need for imaging studies in cases with negative test results. 27, 30, 31 Of the patients available for follow-up, 4 of 34 with below-knee DVT and 3 of 8 with proximal DVT developed signs of post-thrombotic syndrome. This 16.7% (7 of 42) incidence rate suggests that every sixth patient affected by asymptomatic DVT may be exposed to such long-term complications. The overall risk ratio for developing post-thrombotic syndrome was 1:16. Patients without ultrasonographically proven DVT did not develop post-thrombotic syndromerelated morbidity.
Unfortunately, the literature about postthrombotic syndrome is scarce, and the prevalence o f p o s t -t h r o m b o t i c s y n d r o m e f o l l o w i n g asymptomatic DVT remains unknown. The prevalence of patients suffering symptomatic DVT has been reported between 24% and 70%. 8, 11, 23, [32] [33] [34] [35] To the best of our knowledge, only one study has been published that comments on the occurrence of post-thrombotic syndrome after asymptomatic postoperative DVT: Siragusa et al. 12 investigated 98 patients undergoing elective orthopaedic procedures and found that 46.9% presented with an asymptomatic DVT postoperatively; 23.9% of these patients subsequently developed signs of postthrombotic syndrome over a period of 2 to 4 years. Although the follow-up period was considerably longer in their study than in the current study, the proportion of patients affected by post-thrombotic syndrome is only slightly higher and, hence, compares favourably with our results. The development of post-thrombotic syndrome appears to increase with time, as reported in other studies. 10, 35 The findings suggest that symptoms of post-thrombotic syndrome may occur as early as 7 months postoperatively, and that post-thrombotic syndrome generally manifests within 18 to 24 months. 10, 11, 35 Supported by previous studies, 13, 14 our results suggest that post-thrombotic syndrome is an underestimated complication following total joint arthroplasty, especially when considering the long-term morbidity associated with postthrombotic syndrome. Furthermore, the economic effects of such complications are considerable. Bergqvist et al. 36 estimated that the additional long-term health-care costs for post-thrombotic complications was approximately 75% of that of primary DVT. Most orthopaedic surgeons do not deal with the presentation, diagnosis, or treatment of complications related to post-thrombotic syndrome; therefore, they are mostly unaware of the suffering of the patients, and consequently undervalue the morbidity related to post-thrombotic syndrome.
There are several shortcomings in this study, in particular the subjective nature of the assessment of signs and symptoms relating to the classification of post-thrombotic syndrome, despite the use of established assessment criteria. 15 It would have been desirable to have an extended followup period and also to incorporate a control group of patients with asymptomatic DVT receiving no treatment.
Despite thromboprophylaxis and the administration of warfarin and aspirin in cases of asymptomatic DVT, the incidence of post-thrombotic syndrome remains high. The 3 cases of thrombophlebitis in this study went on to develop signs of post-thrombotic syndrome. This raises concern as to whether thrombophlebitis should be considered a precursor of post-thrombotic syndrome.
We demonstrated that post-thrombotic syndrome evolving from asymptomatic DVT has to be treated as a far more common complication than previously recognised. Moreover, overt signs of post-thrombotic syndrome may develop as early as 15 to 18 months postoperatively. Further investigations are needed to determine whether DVT surveillance and subsequent instigation of treatment may mitigate the severity of long-term complications related to post-thrombotic syndrome in patients undergoing joint arthroplasty. It appears that once symptomatic or asymptomatic DVT has developed, treatment is incapable of preventing the occurrence of post-thrombotic syndrome. 37, 38 Our results suggest that proximal extension of DVT into popliteal and femoral veins increases the likelihood of developing post-thrombotic syndrome by a factor of 5. Hence, efforts should concentrate not only on improvements in combating the propagation of calf DVT, but on DVT prevention in general.
